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Adenovirus 2 and 12 early region 1A (Ad2 and Ad12 E1A) proteins were cleaved during cisplatin-induced apoptosis of
Ad-transformed rat and human cells. Cleavage was inhibited in the presence of caspase inhibitors such as Z-VAD-FMK. In
Ad12 transformants both 13S and 12S E1A proteins were cleaved at a similar rate. In Ad2 transformants the E1A 13S
component was appreciably less stable than the 12S component. In in vitro studies Ad2 and Ad12 E1A 13S and Ad2 12S
proteins were rapidly cleaved by caspase 3 whereas Ad12 12S E1A and Ad12 13S E1A were rapidly degraded by caspase
7. Cleavage sites in Ad12 13S proteins for caspase 3 have been determined. Initial cleavage occurred at D24 and D150; this
was followed by cleavage at D204 and D242. Caspase-3-mediated cleavage of Ad12 13S E1A destroyed its ability to bind to
CBP and TBP but interaction between C terminal E1A polypeptides and CtBP was observed. During viral infection Ad5 and
Ad12 E1A 12S proteins were markedly more stable than 13S proteins but no difference was observed in Ad E1A levels in the
absence or presence of the caspase inhibitors Z-VAD-FMK or Z-D(OMe)-E(OMe)-V-D(OMe)-CH2F. Limited caspase 3 and 10
activation occurred during infection with the E1B 19K virus Ad2 pm1722 but little or no activation of caspase 3 was observed
during wt virus infection. Examination of protein cleavage during viral infection of A549 cells showed proteolysis of lamin B
and PARP in response to Ad5 wt and Ad2 pm1722. Protein degradation in response to both viruses was partially inhibited by
Z-VAD-FMK. Following infection of human skin fibroblasts lamin B was degraded, although only limited changes in PARP
levels were observed. We have concluded that Ad E1A is cleaved by caspases during apoptosis but not during viral infection.
However, some of the processes commonly associated with apoptosis occur during viral infection, particularly with E1B 19KINTRODUCTION
Adenovirus early region 1A (Ad E1A) is the first protein
expressed after the initiation of viral infection. It regu-
lates the expression of other viral early proteins by
means of its interaction with the host cell transcriptional
machinery (reviewed in Jones, 1995; Shenk, 1996; Flint
and Shenk, 1997; Gallimore and Turnell, 2001). Ad E1A is
also essential for Ad-mediated transformation although it
transforms cells only rarely in isolation (Houweling et al.,
1980; Gallimore et al., 1985a). The frequency of transfor-
mation is dramatically increased in the presence of co-
operating oncogenes such as Ad E1B or activated ras
(Houweling et al., 1980; Gallimore et al., 1985b; Byrd et
al., 1988).
Two major proteins are translated from the Ad E1A
gene. They are identical except for the presence of a 30-
to 40-amino-acid peptide located toward the C terminus
of the larger molecule and are usually designated by the
sedimentation coefficients of their mRNAs—12S and 13S
(reviewed, for example, in Boulanger and Blair, 1991).
Comparison of the amino acid sequences of Ad E1As
from different virus serotypes has allowed regions of255particular amino acid homology to be identified (Moran
and Mathews, 1987). These conserved regions (CR) form
the binding sites for many of the proteins with which Ad
E1A interacts and their integrity is essential for most
biological properties of Ad E1A (Bayley and Mymryk,
1994). Other regions of Ad E1A, however, are also in-
volved in binding to particular cellular proteins. For ex-
ample, the ATPase components of the 19S proteasome
and p400 interact within the N-terminal region of Ad E1A
(Turnell et al., 2000; Fuchs et al., 2001) while p300/CBP
interacts with the N-terminal region of Ad E1A as well as
CR1 (Wang et al., 1993; Eckner et al., 1994). On the other
hand, the pRb family of proteins binds only through CR1
and CR2 (Dyson et al., 1992). Binding to pRb and p300/
CBP is necessary for induction of DNA synthesis and
apoptosis by Ad E1A (Howe et al., 1990; Querido et al.,
1997a). The third highly conserved region (CR3) is either
entirely or largely missing from the 12S product, depen-
dent on virus serotype. It is particularly important for
interaction with TBP (Geisberg et al., 1994), hSUR2
(Boyer et al., 1999), and ATF2 (Liu and Green, 1994) and
is required for regulation of transcription of both cellular
and viral genes. A further region close to the C terminusmutants, although apoptosis per se is not evident. © 2002
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binding protein (CtBP) (Boyd et al., 1993; Schaeper et al.,
1995).
The relationship between adenoviruses and apoptosis
is complex (White, 1998, 2001; Chinnadurai, 1998; Roul-
ston et al., 1999). It has long been established that
deletion of the gene encoding the 19K E1B protein gives
rise to viruses which appear to induce apoptosis in
infected cells—this is evident as degraded DNA (deg
phenotype) and/or large plaques (lp phenotype) (Still-
man, 1986). This apoptotic response is generally consid-
ered due to activity of Ad E1A and may be either p53
dependent or independent (Lowe and Ruley, 1993; Deb-
bas and White, 1993; Subramanian et al., 1995; Teodoro
et al., 1995). Anti-apoptosis functions are encoded by the
Ad E1B genes with the 19K protein being a functional and
structural homologue of Bcl-2 (Rao et al., 1992).
It is now apparent that a critical initiating event in
certain apoptotic pathways is cleavage of Bid to tBid (Li
et al., 1998; Luo et al., 1998) which promotes homo-
oligomerization of the proapototic Bcl-2 family members
Bax and Bak (Wei et al., 2000; Eskes et al., 2000). This
can, in turn, give rise to some of those events commonly
associated with apoptosis such as cytochrome c release
from mitochondria (Desagher et al., 1999; Wei et al.,
2001). The adenovirus E1B 19K protein binds to Bax
(Farrow et al., 1995; Han et al., 1996) which has been
conformationally altered by tBid (Perez and White, 2000).
Interaction of AdE1B with Bax prevents exposure of the
C-terminal BH2 domain, oligomerization, and TNF--me-
diated apoptosis (Perez and White, 2000; Sundarajan
and White, 2001).
As well as being able to induce apoptosis in isolation,
Ad E1A can also sensitize cells to TNF, resulting in cell
lysis (Chen et al., 1987; Duerksen-Hughes et al., 1989).
Mutational analysis has established that this only occurs
in human cells with viruses lacking the E1B and E3
regions (Gooding et al., 1991a,b). Additionally, it has been
shown that retention of the ability to bind p300 and pRb
is essential for Ad E1A to induce cytolysis (Shisler et al.,
1996). Ad E1A appears to sensitize cells by facilitating
TNF-dependent activation of caspase 8 (White, 2001).
This may be achieved by stimulation of c-FLIPs protea-
some-mediated degradation by AdE1A (White, 2001). The
larger E1B protein (55K) can also inhibit p53-mediated
apoptosis by direct binding to p53 during Ad-induced
transformation or, in cooperation with E4orf6, targeting
p53 for rapid degradation during viral infection (Querido
et al., 1997b, 2001; Steegenga et al., 1998).
The distinctive morphological changes that occur in
apoptotic cells are attributable to the action of a series of
apoptosis-specific proteases termed caspases (Cohen,
1999; Thornberry and Lazebnik, 1998). About 15 of these
enzymes have been identified in mammalian cells so far.
They are normally present in an inactive proenzyme form
and are activated either by autolysis or by cleavage by
other caspases. Caspases have been divided into two
general groups—initiators and effectors (Thornberry and
Lazebnik, 1998). Thus, initiators, such as caspase 8, are
activated by receptor binding, while effectors, such as
caspase 3, are cleaved and activated by other caspases.
A wide variety of cellular proteins serve as substrates for
caspases. For example, enzymes such as FAK (Wen et
al., 1997) and hPAK65 (Lee et al., 1997) (Harvey et al.,
1998), cell cycle regulators such as pRb (Jaenicke et al.,
1996), and p21 (Gervais et al., 1998) proteins involved in
the p53 pathway such as MDM2 (Ehardt et al., 1997) and
ATM (Lu et al., 1998), proteins which play an integral role
in the apoptotic response (e.g., ICAD [also known as
DFF45], an inhibitor of caspase activated nuclease [Liu
et al., 1997] or Bcl2 [Cheng et al., 1997]), as well as a
large number of cytoskeletal components, are degraded
during apoptosis. Thus, in this latter category actin, vi-
mentin, and keratins are all substrates for caspases, as
are catenins and cadherins (Caulin et al., 1997; Branco-
lini et al., 1997; Schmeiser et al., 1998; Schmeiser and
Grand, 1999). While caspase-dependent cleavage of
substrate molecules can serve to inactivate protein func-
tion, this is not always the case. Caspase-mediated pro-
teolysis can result in a truncated product with radically
different properties. Thus, gelsolin degrades actin poly-
mers in a Ca2-dependent process, whereas the cleaved
polypeptide encourages disassembly of actin filaments
in a Ca2-independent manner (Kothakota et al., 1997).
In the study presented here, we have examined the
possibility that the Ad E1A proteins, as well as being able
to induce apoptosis, can also be added to the list of
substrates for caspases. It has been shown that Ad2 and
Ad12 13S proteins are readily degraded in vitro by
caspase 3 but the 12S components are less susceptible.
Ad12 12S protein, however, is a substrate for caspase 7.
Ad E1A is also degraded by a caspase-mediated mech-
anism during Ad/TNF-induced apoptosis. During viral
infection, however, Ad E1A is degraded in a caspase-
independent manner although limited caspase 3 and
caspase 10 activation occurs during infection with cer-
tain mutant and wild-type viruses. PARP and lamin B
degradation has also been noted during viral infection of
A549 cells and this proteolysis has been partially inhib-
ited with caspase inhibitors. These data suggest
caspase-3-independent proteolysis of Ad E1A during ad-
enoviral infection with cellular proteins being degraded
in a caspase-dependent and -independent manner.
RESULTS
Cleavage of Ad E1A during apoptosis
It is now firmly established that a large number of
cellular proteins are substrates for caspases during the
later stages of apoptosis. We were interested to know
whether viral proteins, and in particular adenovirus E1A,
which is able to induce apoptosis, were also degraded.
Apoptosis was induced in BRKs transformed with Ad12
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E1A, by the addition of the DNA damaging agent cispla-
tin. It can be seen from Fig. 1A that increasing concen-
trations of cisplatin caused apoptosis and consequent
degradation of Ad E1A. Figure 1B shows loss of Ad12
E1A after the addition of cisplatin (16 g/ml) and con-
temporary activation of caspase 3 (Fig. 1C). This is evi-
dent as a reduction in level of the inactive 32K pro-
caspase and increase in level of the activated 17K and
12K caspase components. Similar results were obtained
when human cells transformed with Ad2 E1Amutant N
ras were treated with cisplatin. Degradation of Ad2 E1A
and activation of caspase 3 can be clearly observed
(Figs. 1D and 1E). To confirm that the reduction in Ad E1A
was attributable to caspase activity, cells were treated
with cisplatin in the presence and absence of the
caspase inhibitor Z-VAD-FMK (Figs. 2A and 2B, respec-
tively). It can be seen that Z-VAD-FMK inhibits cleavage
of Ad12 E1A and apoptosis—as determined by micro-
scopic examination of acridine-orange-stained cells.
Similar results were obtained for the Ad2 E1A  acti-
vated ras cells treated with cisplatin and Z-VAD-FMK
(data not shown).
Cleavage of Ad E1A by purified caspase 3
Caspases can be broadly divided into initiators and
effectors, the latter class being responsible for the pro-
teolysis of most proteins during apoptosis (Thornberry
and Lazebnik, 1998). To determine which caspases were
capable of degrading Ad E1A, in vitro translated Ad2 and
Ad12 E1A were incubated with purified active caspases.
Figure 3 shows that the larger (i.e., 13S) Ad2 and Ad12
E1A proteins were rapidly cleaved at a site close to the
C or N terminus by caspase 3, causing a small reduction
in molecular weight at early times (i.e., at 4 min). At later
times a much lower molecular weight polypeptide was
the predominant product with both E1A serotypes (Figs.
3A [fragment 3] and 3C). Caspase 3 is much less effec-
tive in the degradation of the 12S proteins. Ad12 E1A 12S
is cleaved to a very limited extent at relatively late times
(Fig. 3B). Cleavage of Ad2 E1A 12S is rapid at a site close
to one end of the protein (as is the case for Ad2 E1A
13S—Fig. 3C) but further degradation does not occur
within the time span of the experiment (Fig. 3D). The in
FIG. 2. Inhibition of apoptosis with Z-VAD-FMK. Ad12 E1A HLBRK7
cells were treated with cisplatin (16 g/ml) for the times indicated
either in the presence (A) or absence of ZVAD-FMK (20 M) (B). Blots
were probed for Ad12 E1A. The percentage of apoptosis was deter-
mined by acridine orange staining.
FIG. 1. Degradation of Ad E1A during apoptosis of adenovirus-
transformed cells. Ad12 E1A HLBRK 7 cells (A, B, and C) or Ad2 E1A 
Nras HER 313A cells (D and E) were treated with cisplatin. Cells were
incubated with cisplatin over a range of doses (A) and harvested after
24 h or with cisplatin (16 g/ml) for the times indicated (B–E). Western
blots were probed with antibodies against Ad12 E1A (A and B), caspase
3 (C and E), or Ad2 E1A (D). The percentage of apoptosis was deter-
mined by acridine orange staining.
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vitro translated proteins were also incubated with puri-
fied caspases 6, 7, and 8 (Fig. 4). As might be expected,
caspase 8 had very limited effect on any of the E1A
proteins (left), since it is an initiator rather than effector
caspase (confirmation that caspase 8 was active is pro-
vided by data presented in Fig. 5). Caspase 7 (center)
rapidly cleaved Ad12 E1A 12S (top center) with loss of a
polypeptide from one end of the molecule. It also had
activity against Ad12 E1A 13S with a slight reduction in
molecular weight being apparent after 15 min. Caspase
7 cleaved the Ad2 E1A 12S and 13S proteins at later
times, giving rise to a slightly truncated product.
Caspase 6 (right) had only very limited activity, being
able to cleave the proteins (with the exception of Ad12
E1A 12S) close to one end at late times. Proteolytic
cleavage by caspase 3 of in vitro translated Ad12 E1A
13S could be inhibited by Z-DEVD-FMK, Z-YVAD-FMK,
and Z-VAD-FMK (data not shown). From these in vitro
studies it appears that both Ad12 E1A 12S and 13S
proteins serve as substrates for caspases, while in the
case of Ad2/5 E1A the 13S protein is much more readily
degraded than the smaller 12S protein. However, when
sufficient caspase 3 was present almost all of the Ad2/5
E1A in lysates of Ad5E1 HER911 (Fig. 5A) or Ad2 E1A 
N ras HER313A cells (data not shown) was degraded.
Similarly, rapid cleavage of PARP and lamin B was seen.
When caspase 8 rather than caspase 3 was added to the
lysates, PARP and lamin B cleavage was also observed,
although at rather later times. Some cleavage of Ad E1A
was noted although this is almost certainly attributable to
secondary effects of the enzyme, for example, the cleav-
age and activation of caspase 3. As expected, the addi-
tion of caspase 8 to the lysates caused rapid cleavage of
the intact caspase 3 present (Fig. 5B). No degradation of
Ad E1A, PARP, or lamin B was observed following incu-
bation in the absence of added caspases (data not
shown).
To compare the relative stabilities of 12S and 13S E1A
products in vivo Ad12 E1A transformed rat cells (Ad12
E1A HLBRK7) and Ad2 E1A  mutant ras transformed
human cells (Ad2 E1A  N ras HER 313A) were treated
with cisplatin. After various times cells were harvested.
Ad E1A 13S and 12S proteins were separated by elec-
trophoresis at pH 8.3 in the absence of SDS but in the
presence of 8 M urea (Grand and Gallimore, 1984). It can
be seen from the Western blots presented in Fig. 6 that
degradation of the 12S and 13S E1A proteins occurred at
a similar rate in the apoptotic Ad12 E1A transformants
(top). In the case of Ad2 E1A, however, the 12S product
was much more stable than the 13S protein (bottom).
Similar results were obtained with Ad12 E1A HLBRK5,
Ad12 E1A  E1B 19K HLBRK2, Ad12 E1A  E1B 19K
HLBRK3, Ad12 E1A  E1B 19K HLBRK4, Ad12 E1A 
Nras HER 414B, Ad12 E1A Nras HER 387.2, Ad2 E1A
Nras HER 313C, and Ad2 E1A  Hras HER 414.2 cells
when they were treated with cisplatin (data not shown).
These results are a reflection of the in vitro observations
presented in Figs. 3 and 4.
Caspase 3 cleavage sites in purified Ad12 13S E1A
To determine the caspase 3 cleavage sites present in
Ad12 E1A13S, purified protein was incubated with
caspase 3 at 37°C. At various times aliquots were with-
drawn from the reaction mix and proteolysis was
stopped by the addition of SDS–PAGE sample buffer.
Afterward, SDS–PAGE polypeptide products were elec-
trophoretically transferred to PVDF membranes. These
were visualized by staining with Ponceau S (1% in 3%
trichloroacetic acid). Areas of the filters staining for
polypeptides were then subjected to amino acid se-
quencing and amino acid analysis. From the sequencing
it is clear where each peptide commences. The results of
the amino acid analysis, approximate molecular weight
(from the SDS–PAGE), and knowledge of other cleavage
sites were used to predict the dimensions of the prod-
ucts of caspase cleavage in this case (Table 1). Thus,
initially cleavage occurs at D24 which results in only the
loss of the N-terminal sequence. At slightly later times
FIG. 3. Proteolytic cleavage of in vitro translated Ad E1A by caspase
3. Ad12 13S (A) and 12S E1A (B) and Ad2 13S E1A (C) and Ad2 12S E1A
(D) were in vitro translated. [35S]Methionine-labeled protein was incu-
bated with caspase 3 for the times indicated. Proteins were fraction-
ated by SDS–PAGE and detected by fluorography.
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the remaining Ad E1A is cleaved at D150, producing two
large fragments encompassing the N and C termini (1–
150 and 151–266, respectively). The N-terminal polypep-
tide is then rapidly degraded, while the C-terminal frag-
ment is probably cleaved at D243 (giving 151–243) and
D205 (giving 205–266). These smaller fragments were
rather longer lived than the larger ones. The three largest
fragments (labeled 1, 2, and 3 in Table 1) seen after
Ponceau S staining had similar molecular weights to
polypeptides 1, 2, and 3 in Fig. 3A. The smaller fragments
could not be readily distinguished after proteolysis of in
vitro translated protein due to the lack of methionine
residues. The determined positions of the cleavage sites
are indicated on the amino acid sequence of the protein
shown in Fig. 7.
Complex formation by Ad12 E1A caspase cleavage
products
As the biological significance of the caspase-medi-
ated cleavage of Ad E1A is not readily apparent, we
decided to examine how the biological activity, as exem-
plified by protein binding, was affected. Thus, Ad12 E1A
was treated with purified caspace 3 for various times.
Aliquots were withdrawn from the reaction mix and frac-
tionated by SDS–PAGE. The cleavage products were
blotted onto nitrocellulose membranes which were then
incubated with a number of Ad E1A binding proteins.
These were chosen to represent proteins which bound to
the N terminus (CBP) central region (TBP) and C termi-
nus (CtBP) of Ad E1A. Protein bound to Ad E1A (or
cleavage products) was detected with antibodies against
GST (CBP–GST and CtBP–GST) or wt protein (TBP). It can
be seen from the blots shown in Fig. 8 that CBP, TBP, and
CtBP all interact with intact Ad E1A (Figs. 8B–8D). CBP
did not bind to any of the cleavage products of Ad12 E1A.
Similarly, TBP was detected almost entirely in complex
with full-length E1A (Fig. 8C), although it can be seen, on
the overexposed autoradiograph shown, that there was
very limited interaction with a minor E1A degradation
product. In contrast, CtBP bound strongly to the small
caspase cleavage products which encompass amino
acids H151 or G205 to the C terminus (Figs. 8D and 7).
FIG. 4. Proteolytic cleavage of in vitro translated Ad E1A with caspases 6, 7, and 8. Ad12 13S and 12S E1A and Ad2 13S and 12S E1A were in vitro
translated. [35S]Methionine-labeled protein was incubated with caspase 8 (left), caspase 7 (center), or caspase 6 (right) for the times indicated.
Proteins were fractionated by SDS–PAGE and detected by fluorography.
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TNF-/Ad E1A induced apoptosis
It is clear from the data presented above that a number
of caspase cleavage sites are present within Ad12 E1A
and that one of these is conserved in E1As from other
viral serotypes (present in CR3). Significantly, we have
shown that cleavage of Ad E1A occurs at these sites
during cisplatin-induced apoptosis. We have gone on to
examine the fate of Ad E1A under two different condi-
tions: first, during Ad E1A-induced apoptosis and, sec-
ond, during wt and mutant viral infection.
It is now well-established that the combination of
TNF and Ad E1A is able to induce apoptosis while each
reagent alone has little effect (Chen et al., 1987; Duerk-
sen-Hughes et al., 1989). A549 cells were infected with
Ad2 pm1722 (50 pfu/cell) and treated with TNF (20
ng/ml) and Z-VAD-FMK (20 M) as indicated (Fig. 9).
Cells were harvested at 24 and 48 h and analyzed by
Western blotting and FACS. FACS analysis presented in
Fig. 9A confirmed that Ad-E1A-sensitized cells treated
with TNF undergo apoptosis [Fig. 9A(iv)] and that this is
inhibited in the presence of Z-VAD-FMK [Fig. 9A(vi)]. Virus
or TNF alone did not induce apoptosis [Figs. 9A(ii) and
9A(iii)]. It can be seen from Fig. 9B that Ad E1A was
cleaved following infection in the presence of TNF and
that this cleavage was inhibited by Z-VAD-FMK. Lamin B
and, to a lesser extent PARP, was also cleaved following
infection with Ad2 pm 1722 but this degradation was
much more extensive in the presence of TNF (Figs. 9C
and 9D). The addition of Z-VAD-FMK inhibited the degra-
dation of these proteins during apoptosis but had only a
limited effect on cleavage which occurred during infec-
tion. Activation of caspase 3 was evident in the apoptotic
samples but did not occur in response to virus or TNF
alone (Fig. 9E).
Ad E1A stability during viral infection
Although it has been clearly demonstrated that
caspase-mediated cleavage of Ad E1A occurs during
both cisplatin- and Ad-E1A-induced apoptosis, the impli-
FIG. 5. Cleavage of Ad E1A in human cell lysates by added caspases
3 and 8. Ad5 E1 HER911 cells were harvested and lysed by sonication
in “caspase buffer” (see text). Activated caspases 3 and 8 were added
and the mixture was incubated at 37°C for the times indicated. Aliquots
were withdrawn and subjected to Western blotting using antibodies
against Ad E1A, caspase 3, PARP, and lamin B as indicated. C, control
untreated lysate of Ad5 E1 HER911 cells.
FIG. 6. Stability of Ad12 and Ad2 E1A 12S and 13S proteins in cells
treated with cisplatin. Ad12 E1A HLBRK 7 cells (A) and Ad2 E1A Nras
HER 313A cells (B) were treated with cisplatin (16 g/ml) for the times
shown. Proteins were fractionated by PAGE in the presence of 8 M urea
(but in the absence of SDS) and Western blotted using antibodies
against Ad12 or Ad2 E1A as shown. The position of migration of the 12S
and 13S components is indicated.
TABLE 1
Products of Caspase 3 Proteolytic Activity against Ad12 13S E1A
N-terminal
sequences
Residue
number
Recognition
sequence
Approximate dimensions
of polypeptide
1. MRTEM 1- — 1–266
2. NFFNE 25- HLVD 25–266
3. MRTEM 1- FQLD 1–150
4. HPELP 151- FQLD 151–266
5. HPELP 151- FQLD 151–243
SILD
6. GDERP 205- SILD 205–266
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cations of these observations for the fate of E1A during
viral infection are not clear. It has been suggested that
apoptosis does not occur during wt adenoviral infection
although it is considered that the mutant Ad E1B 19K
viruses can produce an apoptotic response. Interest-
ingly, the addition of Z-VAD-FMK during wt virus infection
caused increased production of progeny virus but also
reduced release of viral particles (Chiou and White,
1998). Against this background we considered that it
would be appropriate to examine the fate of Ad E1A
following infection with wt and Ad E1B 19K viruses.
Initially, an Ad E1B 19K virus (Ad2 pm1722) was stud-
ied. It has previously been shown that pm1722 produced
extreme cytopathic effects similar to apoptosis after in-
fection of HeLa cells (Barker and Berk, 1987) and this has
also been shown to occur after infection of human fibro-
blasts and, to a lesser extent, A549 cells (our data not
shown). However, the Western blots presented in Figs.
10A and 10B indicate that the overall level of Ad E1A
expression is unaffected by the presence of the caspase
inhibitor Z-VAD-FMK. When samples from infected cells
were fractionated on gels in the presence of urea it was
seen that the 12S E1A protein was considerably more
stable than the 13S product (Figs. 10C–10F). Similar pat-
terns of protein expression were observed in the pres-
ence and absence of Z-VAD-FMK. Infection with wt Ad5
and Ad12 gave a similar pattern of E1A expression to that
seen with Ad2 pm1722 (Figs. 10D and 10E). For both
viruses the smaller 12S protein was appreciably more
stable than the 13S protein. No difference was seen
when infection with Ad5 and Ad12 wt occurred in the
presence of Z-VAD-FMK or Z-D(OMe)-E(OMe)-V-D(OMe)-
CH2F (data not shown). Similarly, infection of A549 cells
with Ad12 pm700, an Ad12 E1B19K virus which displays
a cytocidal and large plaque phenotype (Edbauer et al.,
FIG. 7. Caspase 3 cleavage sites in Ad12 E1A. The amino acid sequences of Ad2/5 and Ad12 E1A proteins are shown. The determined cleavage sites
in the Ad12 protein are indicated (1). The dimensions of conserved regions (CR) 1, 2, and 3 and the oncogenic spacer region in Ad12 are also shown.
FIG. 8. Interaction of Ad12 E1A cleavage products with E1A binding
proteins. Ad12 E1A was incubated with caspase 3 for the times indicated.
Cleavage products were separated by SDS–PAGE and electrophoretically
transferred to nitrocellulose membranes. The membranes were incubated
for 2 h with (B) CBP fragment–GST, (C) in vitro translated TBP, or (D)
CtBP1–GST. After washing, bound proteins were detected with antibodies
against GST (B and D) or TBP. A shows a normal Western blot of the Ad12
E1A caspase 3 cleavage products. Cleavage products are indicated.
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1988), showed similar levels of Ad12 E1A expression in
the presence and absence of Z-VAD-FMK (data not
shown).
We have concluded that a “normal” apoptotic response
based on the activation of caspase 3 triggered during
infection is not responsible for Ad E1A degradation.
However, we have extended this study and examined to
what extent protein degradation, usually associated with
apoptosis, occurs during infection with Ad5 wt and Ad2
pm1722.
Caspase activation and cleavage of cellular proteins
during adenovirus infection
Although little difference in Ad E1A expression during
viral infection was observed with caspase inhibitors, we
considered the possibility that some limited activation of
caspases might occur, particularly in view of previous
observations (Chiou and White, 1998). Western blotting
studies suggested slight caspase 3 activation during
infection of A549 cells with Ad2 pm1722 and Ad12 pm700
and this was not appreciably affected by Z-VAD-FMK
(Figs. 11A and 11B and data not shown, respectively).
Interestingly, an increase in level of procaspase 3 ex-
pression was observed during the later stages of viral
infection (Figs. 11A and 11B). Virtually no activation of
caspase 3 was seen during wt Ad5 or Ad12 wt infection
(data not shown). Activation of caspase 3 was rather
more marked following infection of fibroblasts with Ad2
pm1722 than A549 cells [Figs. 11A and 13B(ii)].
Analysis of caspase 10 expression was also under-
taken. Appreciable activation (evident as a reduction in
the level of the 58K procaspase signal in the Western
blots) was apparent during cisplatin-induced apoptosis
of Ad E1A expressing transformed cells (data not
FIG. 9. Stability of Ad2 E1A in the presence of TNF. A549 cells were infected with Ad2 pm1722 (50 pfu/cell) in the presence or absence of TNF
(20 ng/ml) and Z-VAD-FMK (20 M) as indicated. Cells were harvested after 24 or 48 h, as shown, and subjected to FACS analysis (A) or PAGE and
Western blotting (B–E). FACS analysis was carried out on 24-h samples treated with (i), no additions; (ii) TNF; (iii) Ad2 pm1722; (iv) Ad2 pm1722 in
the presence of TNF; (v) Ad2 pm1722 in the presence of Z-VAD-FMK, and (vi) Ad2 pm1722, TNF, and Z-VAD-FMK. The percentage of cells in the
sub G1 peak (i.e., apoptotic) is shown in each panel. Western blots were probed with antibodies against (B) Ad2 E1A; (C) lamin B; (D) PARP, and (E)
procaspase 3. The proteolytic fragments of Ad E1A are indicated in B.
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shown). However, during viral infection with Ad2 pm1722
and Ad5 and Ad12 wt activation of caspase 10 was more
limited although obvious (Figs. 11C–11F). The addition of
the inhibitor Z-VAD-FMK reduced the activation of
caspase 10 slightly (compare Figs. 11C and 11D). No
activation of caspases 6, 7, and 8 was observed during
infection with any of the viruses (data not shown). How-
ever, it was observed that purified caspase 10 degraded
[35S]methionine-labelled in vitro translated Ad E1A to
only a very limited extent.
The fate of two well-characterized caspase substrates
was also examined during viral infection of A549 cells
and human fibroblasts. Lamin B was rapidly degraded
during wt Ad5 and Ad2 pm1722 infection of A549 cells;
this was inhibited to a certain extent in the presence of
Z-VAD-FMK, particularly following infection with pm1722
(Figs. 12A–12D). The stability of PARP was also exam-
ined. During infection of A549 cells with wt Ad5 and Ad2
pm1722 some degradation of PARP took place and this
was inhibited with Z-VAD-FMK (Figs. 12E–12H).
Rather different results were obtained following the
infection of human skin fibroblasts (Fig. 13). Ad E1A was
appreciably more stable, with the level of expression still
increasing after several days (compare Fig. 13A with 10
and 9B, although it should be noted that in the A549 cells,
unlike the fibroblasts, infection went virtually to comple-
tion). Caspase 3 activation was much more marked dur-
ing infection of fibroblasts with Ad2 pm1722 [Fig. 13B(ii)]
and this was inhibited by Z-VAD-FMK [Fig. 13B(iv)]. As
with A549 cells lamin B was cleaved during Ad2 pm1722
infection (Fig. 13C) and Ad5 wt infection (data not
shown). Limited inhibition of this cleavage was observed
in the presence of Z-VAD-FMK (Fig. 13C). Degradation of
lamin B following Ad5 wt infection of fibroblasts was
similar to that shown in Fig. 13C for Ad2 pm1722. No
degradation of PARP was observed with Ad2 pm1722 or
Ad5 wt, although some increase in expression occurred
at late times (data not shown). Thus, it is apparent that
during infection with wt virus as well as with E1B 19K
virus a number of proteolytic events associated with
apoptosis take place, even though caspase 3, 6, 7, and 8
activation is strictly limited. The effects vary with different
target cell types.
DISCUSSION
The relationship between adenoviruses and apoptosis
is complex (Roulston et al., 1999; White, 2001). Expres-
sion of Ad E1A causes p53-mediated and p53-indepen-
dent apoptosis following transfection into mammalian
cells (Lowe and Ruley, 1993; Debbas and White, 1993;
Subramanian et al., 1995; Teodoro et al., 1995). Infection
of human cells with mutant viruses lacking the gene
encoding the E1B 19K protein also appears to cause
apoptosis evident as a deg (DNA degradation), lp
(large plaque), or cyt (cytolysis) phenotype (reviewed in
Stillman, 1986). Other adenovirus proteins are also in-
volved in apoptosis—for example, E4 orf4 has been
shown to induce cell death by a p53-independent mech-
anism (Lavoie et al., 1998). In addition, products of the E3
gene protect virally infected cells from apoptosis induced
by the host’s immune system (reviewed in Wold and
Tollefson, 1998). Simplistically, it might be expected that
adenoviruses would try to inhibit apoptosis during the
early stages of infection to minimize the host’s immune
response so that viral replication has sufficient time to go
FIG. 10. Expression of Ad E1A during viral infection. A549 cells were
infected with Ad2 pm1722 (50 pfu/cell) (A–D) for the times shown either
in the presence (A and C) or in the absence (B, D, E, and F) of
Z-VAD-FMK or with Ad12 wt (E) or Ad5 wt (F). Proteins were fractionated
by PAGE in the presence of SDS (A and B) or 8 M urea (C–F). Ad E1A
was detected by Western blotting as indicated.
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to completion. Later cell lysis, to allow the release of the
viral progeny, might be expected to utilize part of the
cellular apoptotic mechanism. Up to now, however, most
evidence supports the contention that during wild-type
infection adenoviruses inhibit most aspects of apoptosis.
Lysis of infected cells appears to be mediated by ade-
novirus death protein, an 11.6K molecular weight glyco-
sylated polypeptide, encoded by the E3 region, which is
expressed at high levels very late in infection (Tollefson
et al., 1996a,b) and not by apoptosis.
During apoptosis many cellular proteins are degraded
by caspases. We considered that it would be of interest
to investigate whether caspase-mediated proteolysis
could play a part in the observed reduction in level of
E1A as adenovirus infection progresses. Initially, it was
shown that in stable transformed human and rat cell
lines expressing Ad2, Ad5, or Ad12 E1A induction of
apoptosis with the DNA damaging agent cisplatin re-
sulted in E1A degradation (Fig. 1). Apoptosis and E1A
proteolysis were inhibited by Z-VAD-FMK (Fig. 2) and
other caspase inhibitors (data not shown). When the
stability of the two major Ad E1A components was com-
pared (Fig. 6) it was noted that in Ad12 expressing cells
both the 12S and the 13S proteins were degraded at the
same rate. However, in the case of Ad2 and Ad5 E1A
expressing cells the addition of cisplatin caused more
rapid proteolysis of the larger 13S protein (Fig. 6).
Results of in vitro studies using purified Ad E1A pro-
teins and caspases were consistent with these observa-
tions. Thus, both Ad2 and Ad12 13S proteins were rapidly
cleaved by caspase 3 (Fig. 3). The Ad12 12S (and Ad12
13S) protein was cleaved by caspase 7 while the Ad2
E1A 12S protein was rather more stable, with only limited
cleavage taking place (Figs. 3 and 4). Caspase 7 also
had limited effect on purified Ad2 E1A 13S protein (Fig.
4). When purified caspase 3 was added to lysates of Ad
transformed cells E1A was cleaved together with PARP
and lamin B (Fig. 5). This is consistent with data obtained
from the in vitro experiments (Figs. 3 and 4). The pres-
ence of Ad E1B 19K protein (in the Ad E1 transformants)
did not protect the proteins from caspase activity as it
exerts its anti-apoptotic effects upstream of caspase
activation. Purified caspase 8 also caused some prote-
olysis of Ad E1A in this assay (Fig. 5) due to its ability to
directly cleave and activate caspase 3 (Fig. 5B).
Cleavage of Ad E1A in vitro with caspases 3, 6, and 7
generally results in an initial small reduction in molecular
weight (Figs. 3 and 4). Studies with the Ad12 13S protein
indicate that this is due to cleavage C terminal to D24
(Fig. 7). This residue is not conserved in Ad2/5 but it is
likely that cleavage occurs at D21 (D30 is an unlikely
cleavage site due to the C-terminal sequence NLPPP).
Cleavage does not occur at D24 in Ad12 12S E1A with
either caspase 3 or 7 (Figs. 3 and 4). The second major
FIG. 11. Caspase expression during adenovirus infection. A549 cells were infected for the times shown with Ad2 pm1722 (A–D), Ad5 wt (E), or Ad12
wt (F) in the presence (B and C) or absence (A, D, E, and F) of ZVAD-FMK (20 M). Proteins were fractionated by SDS–PAGE and Western blotted
for caspase 3 (A and B) or procaspase 10 (C–F).
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site of cleavage in Ad12 E1A 13S occurs at D150 in CR3
(Fig. 7 and Table 1). This residue is conserved in the
Ad2/5 13S protein, although the C-terminal sequence
differs—HPEL in Ad12 and YVEH in Ad2/5. Whether
cleavage occurs at D150 in Ad12 12S E1A has not been
definitively demonstrated but seems likely. The stability
of Ad2/5 E1A 12S protein can be explained by the ab-
sence of CR3—removing the probable cleavage site at
D145, equivalent to Ad12 D150. The comparable residue
is present in both 12S and 13S Ad12 proteins. At later
stages of treatment of Ad12 13S E1A with caspase 3
proteolysis occurs at aspartic acid residues in the C-
terminal domain (encoded by exon 2) (Fig. 7 and Table 1).
Similar sequences are present in the Ad2/5 proteins.
Probable cleavage sites in Ad2/5 13S E1A occur at D230,
D233, and D271, although this has not been demon-
strated experimentally. It appears, therefore, that both
Ad2/5 13S E1A and both Ad12 E1A proteins are progres-
sively degraded from the N terminus. This results in the
loss of the N-terminal domain essential for binding p300/
CBP, p400, and proteasome components, followed by
destruction of the TBP binding site in CR3 and separation
FIG. 12. Lamin B and PARP expression during adenovirus infection. A549 cells were infected with Ad5 wt (A, B, E, and F) or Ad2 pm1722 (C, D, G,
and H) for the times indicated either in the presence (B, D, F, and H) or in the absence (A, C, E, and G) of ZVAD-FMK. Proteins were fractionated by
SDS–PAGE and Western blots were probed with antibodies against lamin B (A–D) or PARP (E–H) as indicated. The major lamin B caspase cleavage
product is indicated.
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of the C-terminal domain from the N-terminal region
containing CR1 and CR2. Finally, these large polypep-
tides are further degraded.
The effect of caspase cleavage on the ability of Ad E1A
to interact with a number of its known binding partners
was investigated (Fig. 8). Three representative binding
proteins were examined—CBP, which interacts with the
N-terminal region of E1A (Wang et al., 1993), TBP, which
has been considered to bind predominantly to CR3 (Hori-
koshi et al., 1991; Lee et al., 1991), and CtBP, which
interacts very close to the C terminus (Boyd et al., 1993).
CBP was shown not to interact with any of the cleavage
products of Ad12 E1A, consistent with the observation
that loss of the N-terminal region is an early event during
caspase-mediated cleavage of Ad12 E1A. Only a very
limited interaction of TBP was observed. If the major site
of interaction were in CR3 it might be expected to bind to
Ad12E1A25-266—which contains intact CR3. However,
other more recent evidence suggests that TBP may in-
teract preferentially with the N terminus (Song et al.,
1995; Boyd et al., 2002). Data presented here are consis-
tent with this suggestion. The ability of C-terminal frag-
ments of E1A to interact with CtBP is shown in Fig. 8D.
Previously, binding of a C-terminal chymotryptic peptide
of Ad12E1A (residues 187–266) has been demonstrated
(Molloy et al., 2000). These are, of course, in vitro studies
and within the apoptotic cell caspase-mediated degra-
dation of Ad E1A binding proteins will also be occurring;
for example, degradation of pRb has been established
for some years (Jaenicke et al., 1996). It is beyond the
scope of this investigation to determine the stability and
binding capabilities of all of the known Ad E1A binding
proteins but we have noted that CtBP1 and CtBP2 are
relatively unaffected during apoptosis of Ad-E1A-ex-
pressing cells while CBP, p300, p130, p107, and TBP are
degraded at similar times to Ad E1A after treatment with
FIG. 13. Infection of human fibroblasts with adenoviruses. Human fibroblasts were infected with wt Ad5 [A(i) and A(iii), B(i) and B(iii)] or Ad2 pm1722
[A(ii) and A(iv), B(ii) and B(iv), C(i) and C(ii)] in the absence [A(i) and A(ii), B(i) and B(ii), and C(i)] or presence [A(iii) and A(iv), B(iii) and B(iv), and C(ii)]
of Z-VAD-FMK. Cells were harvested and proteins fractionated by SDS–PAGE. Western blots were probed with antibodies against A, Ad2/5 E1A; B,
caspase 3; C, lamin B. Infections were for the times indicated at an infectivity of 50 pfu/cell.
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cisplatin. The caspase-mediated proteolysis of Ad E1A
and the Ad E1A binding proteins occurs slightly after the
observed breakdown of PARP and lamin B in the system
investigated. Whether the observation that a caspase-
generated peptide from Ad E1A is able to bind to, and
presumably neutralize the activity of, CtBP, a protein
which is not degraded in apoptotic cells, is of particular
significance will have to await further investigation. How-
ever, it is interesting to note that peptide fragments of Ad
E1A do not appear to bind to the partner proteins which
are themselves substrates for caspases in apoptotic
cells.
These studies were extended to consider the fate of
Ad E1A when it is responsible for producing an apoptotic
response. It is now well-established that following infec-
tion with an Ad E1B mutant virus and treatment with
TNF cells become apoptotic. We have demonstrated
that during this process Ad E1A is degraded by
caspases (Fig. 9). In the absence of TNF no character-
istic Ad E1A degradation product was visible. However,
in the presence of TNF but in the absence of Z-VAD-
FMK a truncated Ad2 E1A protein could be distinguished
(Fig. 9B). This was of comparable size to the Ad2 E1A
degradation product seen during cisplatin treatment of
Ad2 expressing cells (Fig. 1D).
Significantly, the level of expression of Ad E1A was
similar during wt and mutant virus infection in the pres-
ence and absence of the caspase inhibitor Z-VAD-FMK.
During viral infection the 13S Ad E1A component was
shown to be much less stable than the smaller protein
(Fig. 10). This loss of Ad 13S E1A is probably not due to
the action of caspases since the addition of caspase
inhibitors had very little effect on Ad E1A expression
levels (Fig. 10 and data not shown). Consistent with this,
only marginal activation of caspase 3 was observed
during wt viral infection, although limited conversion of
inactive procaspase 3 to the active enzyme was appar-
ent during infection with Ad2 pm1722 (compare Figs. 1
and 11). It is probably to be expected that caspase 3
would not be activated during wt viral infection as this
would lead to activation of ICAD, activation of the nucle-
ase CAD, and cleavage of viral and cellular DNA (Liu et
al., 1997). It is interesting to note, however, that caspase
3 activation was more marked following Ad2 pm1722
infection of human fibroblasts than of A549 cells (com-
pare Figs. 11A and 13B). No activation of caspases 6, 7,
and 8 (data not shown) was observed although limited
Z-VAD-FMK inhibitable loss of procaspase 10 was seen
(Figs. 11C–11F). Thus, although it is generally considered
that the 19K viruses induce an apoptotic state, many of
the diagnostic features associated with it (in particular
caspase activation) are not as prominent as those seen
following the addition of reagents which produce a clas-
sical apoptotic response (e.g., DNA damaging reagents).
These studies were extended to see to what extent the
generalized caspase-mediated proteolysis normally as-
sociated with apoptosis occurred during viral infection.
Degradation of lamin B and PARP has previously been
found to be an accurate diagnostic marker of apoptosis.
In the studies presented here cleavage of lamin B was
observed during viral infection of A549 cells and human
fibroblasts (Figs. 12 and 13C). This occurred both in the
absence and in the presence of Z-VAD-FMK and oc-
curred with Ad E1B 19K as well as wt virus. However,
some limited inhibition of lamin B proteolysis was ob-
served following viral infection of A549 cells and fibro-
blasts when the caspase inhibitor was present. It has
previously been observed that proteolysis of PARP in
response to infection with Ad5 E1B 19K virus (dl 337)
occurred irrespective of the presence of Z-VAD-FMK
(Chiou and White, 1998). In our studies using A549 cells
PARP was degraded following infection with wt or mutant
viruses. In both cases proteolysis was reduced to some
extent by Z-VAD-FMK (Figs. 12E–12H). Only slight prote-
olysis of PARP was seen following the infection of human
skin fibroblasts. Again, these data are further evidence of
the differences between cell death due to viral infection,
even by Ad E1B 19K mutants, and apoptosis. In the
former case protein degradation appears to be some-
what limited and to be largely, although not entirely,
caspase independent. It is possible, therefore, that an
alternative proteolytic system could be activated during
viral infection and that this could produce some, but not
all, of the morphological effects usually associated with
apoptosis.
In summary, we have demonstrated here significant
caspase-mediated cleavage of Ad E1A during apoptosis
but not during viral infection when degradation of Ad E1A
can be attributed to non-caspase-mediated proteolysis.
Lamin B and PARP cleavage during infection is probably
primarily due to the action of virally activated proteases
which are not inhibited by caspase inhibitors. The deg-
radation of these proteins is host cell type dependent.
MATERIALS AND METHODS
Cell lines and virus infection
Ad12 E1A HLBRK and Ad12 E1A E1B 19K HLBRK cell
lines were produced by transfection of DNA encoding
Ad12 E1A (AccIH fragment) or Ad12 E1A and Ad12 E1B
19K (HindIII G fragment) into hooded Lister baby rat
kidney (HLBRK) cells (Gallimore et al., 1985b). Ad12
E1A  mutant ras HER and Ad2 E1A  mutant ras HER
cell lines were produced by transfection of Ad E1A DNA
together with activated mutant N or H ras DNA into
human embryo retinoblast (HER) cells (Byrd et al., 1988).
The following lines were used in this study: Ad12 E1A
HLBRK 7, Ad12 E1A HLBRK5, Ad12 E1A  E1B 19K
HLBRK2, Ad12 E1A E1B 19K HLBRK3, Ad12 E1A E1B
19K HLBRK4, Ad12 E1A  H ras HER 414B, Ad12 E1A 
N ras HER 387.2, Ad2 E1A N ras HER 313A, Ad2 E1A
N ras HER 313C, Ad2 E1A  H ras HER 414.2. A549 cells
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derive from a human small cell lung carcinoma and were
used for some viral infection experiments. A549 cells
were infected with wt Ad5 and Ad12 and with the E1B
19K viruses Ad2 pm1722 (Barker and Berk, 1987) and
Ad12 pm700 (Edbauer et al., 1988). Ad2 pm1722 is in a
dl309 background, lacking part of the E3 gene. Fibro-
blasts from an adult male donor were infected with wt
Ad5 or with Ad2 pm1722. Most infections were at 50
pfu/cell, although occasionally an infectivity of 200 pfu/
cell was used. All cells were grown in DMEM buffered
with HEPES containing glutamine (2 mM) and FCS (8%).
Apoptosis
Apoptosis was induced by the addition of cisplatin to
the tissue culture medium at a concentration of 15–30
g/ml, depending on the cell line. The extent of apopto-
sis was estimated by counting the acridine-orange-
stained cells or by FACS analysis. FACS analysis was
carried out essentially as described by Grand et al.
(1998a). Briefly, cells were harvested following trypsiniza-
tion and fixed in 70% ethanol at 20°C. Cells were then
treated with RNAse A (50 g/ml) and labeled with pro-
pidium iodide (5 g/ml) prior to analysis using a Coulter
Epics XL flow cytometer. The percentage of cells in each
phase of the cycle was determined using a multicycle
version of 2.53 (Phoenix). DNA profiles were processed
using Win MDI version 2.5.
To examine Ad E1A sensitization to TNF-induced
cytolysis A549 cells were infected with Ad2 pm1722 (50
pfu/cell) and treated with TNF (20 ng/ml). Experiments
were carried out in the presence and absence of Z-VAD-
FMK (20 M).
Western blotting
Cells were washed with cold saline, dislodged from
the tissue culture plastic, and pelleted by centrifugation.
Cells were solubilized in 9 M urea, 50 mM Tris HCl, pH
7.4, 0.15 M -mercaptoethanol. Aliquots containing 30 g
protein were subjected to SDS–PAGE in the presence of
0.1 M Tris, 0.1 M bicine, pH 8.3, and 0.1% SDS. Western
blotting was carried out using conventional protocols.
Proteins were also fractionated on 15% polyacrylamide
gels run in the presence of 7 M urea, 15 mM Tris, 93 mM
glycine, pH 8.3 (but in the absence of SDS), followed by
Western blotting (Grand and Gallimore, 1984). “Urea gels”
have been used in the past to separate relatively low-
molecular-weight acidic proteins which have marked dif-
ferences in charge or conformation rather than size, for
example, different phosphorylated or Ca2-bound forms
(Head and Perry, 1974). Proteins are retained in solution
in the presence of the urea and will migrate into the gel
so long as they are highly negatively charged (a prepon-
derance of acidic amino acids) and comprise less than
about 400 residues.
For the detection of interaction of E1A caspase 3
cleavage products with E1A binding proteins Ad12 E1A
(20 g) was incubated with purified caspase 3 at 37°C
as described below. After SDS–PAGE and electro-
phoretic transfer nitrocellulose membranes were incu-
bated for 2 h with CBP–GST fragment (2 g/ml), CtBP1–
GST (2 g/ml), or in vitro translated TBP (50 l reaction
mix). After the washings, bound CBP or CtBP1 were
detected using an antibody raised against GST (Amer-
sham Pharmacia). Bound TBP was detected using an
antibody against the intact protein (Upstate Biotechnol-
ogy, Inc.).
Antibodies
Ad12 E1A was usually detected with a mouse mono-
clonal antibody (E1A mab13) and occasionally with rat
tumor bearer serum or a sheep polyclonal antibody.
Ad2/5 E1A was detected with the mouse monoclonal
M58 (PharMingen). Neither of these reagents reacted
with any cellular polypeptide—nor did they react with
any lower molecular weight Ad E1A product in nonapop-
totic cells. Antibodies against caspases 3 and 7 were
from PharMingen. Antibodies against caspases 6, 8, and
10 were from Upstate Biotechnology, Inc. Lamin B was
detected with a goat polyclonal antibody from Santa Cruz
Biotech. PARP antibody (monoclonal clone C-2-10) was
from Sigma. TNF was from R&D Systems.
Protein preparation
Ad12 E1A 13S was expressed in Escherichia coli and
purified under denaturing conditions as previously de-
scribed (Grand et al., 1998b). Protein was renatured by
prolonged dialysis against 10 mM NH4HCO3, pH 7.9. Ad2,
Ad12 E1A, and TBP, cloned into T7-driven expression
plasmids, were in vitro translated using the TNT-coupled
rabbit-reticulocyte system (Promega) in the presence of
L--[35S]methionine, according to the manufacturer’s in-
structions.
CtBP1 and the Ad E1A binding fragment of CBP (amino
acids 1460–1891) were expressed in E. coli as GST
fusion proteins and purified using glutathione–agarose
beads.
Amino acid sequencing was carried out on peptides
blotted onto PVDF membranes using a Perkin–Elmer/
AB1 473A sequencer by Alta Bioscience, University of
Birmingham. Five cycles were performed on each pep-
tide.
Caspase assays
In vitro translated L--[35S]methionine Ad E1A (50 l)
was incubated at 37°C with purified caspases (3, 6, 7,
and 8 [PharMingen]) in 25 mM PIPES, pH 7.3, 10 mM DTT,
1 mM EDTA, 10% sucrose, 0.1% CHAPS, 0.1 M NaCl
(caspase buffer). Aliquots were withdrawn at appropriate
times and the reaction was stopped by the addition of
SDS sample buffer. Purified Ad12 E1A 13S protein was
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incubated with purified caspases 3, 6, 7, and 8 at 37°C in
caspase buffer. Aliquots were withdrawn at appropriate
times and the reaction was stopped with SDS sample
buffer.
Cells (Ad2E1A  Nras HER313A, Ad5E1HER911, and
A549) were washed twice with ice-cold saline and har-
vested by aspiration. Caspase buffer (0.5 ml) was added
to the cell pellets, which were then sonicated. Insoluble
material was removed by centrifugation (35K rpm for 30
min). Protein lysate (100 g) was incubated with purified
caspase 3 or 8 at 37°C. Aliquots were withdrawn at
appropriate times and added to SDS sample buffer. Pro-
tein cleavage was detected by Western blotting.
Apoptosis and in vitro caspase activity was inhibited
by the addition of Z-VAD-FMK, Z-DEVD-FMK, and Z-YVAD-
FMK. The inhibitors were present in the tissue culture
medium at a concentration of 20 M.
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